New Drug Evaluations are concise, structured reviews of new drugs recently launched within the NHS. These documents seek to provide a brief overview of the efficacy, safety and cost of new drugs. The primary audiences
are primary care healthcare professionals in Northern and Yorkshire such as General Practitioners, Prescribing Advisors, Community/Primary Care Pharmacists and Nurse Prescribers. They are also found be useful by hospital practitioners and Drug and Therapeutics Committees.
This information is produced for use by NHS healthcare professionals. See site disclaimer.
